Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Operating within the medical imaging sector, Diagnostic Medical Systems S.A. serves both French and international markets. The company provides a comprehensive suite of solutions, encompassing radiography/fluoroscopy, mammography, bone densitometry, and advanced 3D reconstruction. Its product portfolio also includes specialized retrofit kits, mobile imaging units, chest and bone room systems, and mobile C-arms. Beyond imaging, the firm offers cutting-edge technologies for the treatment of osteoarthritis and regenerative medicine through fat stem cell injections. Founded in 1979, Diagnostic Medical Systems S.A. is headquartered in Mauguio, France.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITD.
Target Price
The average target price of ALDMS.PA is 2.20 and suggests 86.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to